Yan Yang

Title: Yan Yang - Innovator in Multispecific Binding Molecules

Introduction

Yan Yang is a notable inventor based in Mamaroneck, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding molecules. With a total of 3 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Yan Yang's latest patents include groundbreaking advancements in N-terminal scFv multispecific binding molecules. These multispecific binding molecules (MBMs) comprise an N-terminal scFv, a first Fab, and a second Fab. His patents also cover MBM conjugates that include cytotoxic or cytostatic agents, as well as pharmaceutical compositions containing these MBMs and MBM conjugates. Furthermore, he has developed methods for using the MBMs, MBM conjugates, and pharmaceutical compositions for treating cancer. His work also involves nucleic acids encoding the MBMs, cells engineered to express the MBMs, and methods of producing these innovative molecules.

Career Highlights

Yan Yang is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of scientific research and innovation. His expertise in the field has positioned him as a key player in the development of new therapeutic strategies.

Collaborations

Throughout his career, Yan has collaborated with esteemed colleagues, including Yang Shen and Ann-Hwee Lee, who contribute to the dynamic research environment at Regeneron Pharmaceuticals.

Conclusion

Yan Yang's contributions to the field of biotechnology, particularly in the area of multispecific binding molecules, highlight his innovative spirit and dedication to advancing cancer treatment. His work continues to inspire and pave the way for future breakthroughs in medical science.